MTND3P8

Across TCGA pan-cancer cohorts, MTND3P8 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MTND3P8 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MTND3P8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND3P8 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

SKCM, TGCT, and PRAD are the cancer types where MTND3P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	III,IV	0.058	0.648	.001	45	view →
TGCT	OS	Tertile	All	0.542	0.969	<.001	36	view →
PRAD	OS	Tertile	All	0.909	0.990	.007	12	view →
STAD	DFS	Tertile	III,IV	0.725	0.534	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MTND3P8–SKCM (DFS)

Open the SKCM breakdown →